Reported results
- GAAP net sales were $140 million, a decrease of 3% year-over-year.
- GAAP net loss was $47 million, or $1.76 per share.
- Adjusted EBITDA (a non-GAAP measure) was $9 million.
- GAAP net cash used in operating activities was $8 million.
- Adjusted free cash flow (a non-GAAP measure) was negative $16 million.
- Non-GAAP adjusted net loss was $32,109 thousand, or an adjusted loss per share of $1.21.
Guidance
- Maintains expectation for a 5–10% year-over-year increase in graphite electrode sales volume for full-year 2026.
- Anticipates a mid-single-digit percentage increase in weighted-average realized pricing for the fourth quarter of 2026 compared to the third quarter of 2026.
- Expects a low-single-digit percentage decline in non-GAAP cash cost of goods sold per MT for full-year 2026 compared to 2025.
- Anticipates full-year 2026 capital expenditures of approximately $35 million.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-23 (8-K, Item 2.02). Read the original filing on sec.gov.
